NCT00769288
- Conditions
- Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +107 more
- Locations
-
- Wayne State University Detroit, Michigan, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
3,646 public trials
848 recruiting studies
Lymphoma trial results
Completed
A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation
NCT01068301
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +25 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT00656812
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Universitätsklinikum Graz Graz, Austria
- Universitaetsklinik Innsbruck/ Klinik für Innere Medizin Innsbruck, Austria
- Krankenhaus der Stadt Linz Linz, Austria
- Universitaetsklinik f. Innere Medizin III Salzburg, Austria
NCT01790815
- Conditions
- Deficiency Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Mirriah Health District Mirriah, Niger
NCT01482754
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- National University Hospital Singapore
NCT00185445
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Bologna, BO, Italy
- Cesena, FC, Italy
- Forlì, FC, Italy
- Genova, GE, Italy
Completed
Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL
NCT00311129
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Nagoya, Aichi-ken, Japan
- Kashiwa-shi, Chiba, Japan
- Isehara-shi, Kanagawa, Japan
Completed
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
NCT01129180
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +35 more
- Locations
-
- Ohio State University Medical Center Columbus, Ohio, United States
Completed
Velcade in MALT Lymphoma Patients
NCT00373906
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
Not specified
NCT01010295
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Hospital del Salvador Providencia, Santiago, Chile
- Ospedale San Raffaele, Department of Oncology Milan, Italy
- S. Matteo Pavia, Italy
- A.O. Bianchi-Melacrino-Morelli, Divisione di Ematologia Reggio Calabria, Italy